New found cannabinoid CBG to change the game of medical cannabis.

27 February 2024 The tests have been carried out by Cannabics Pharmaceuticals at the company’s High Through-put Screening (HTS) facility in Israel. The tests have shown that the cannabinoids and CBG (Cannabigerol) both exhibit anti-tumour properties after being tested on human Gastrointestinal Cancer Cells. CBG is a non-psychoactive cannabinoid and is one of the naturally […]